Insider trades

David A. Spellman, CFO of Akebia Therapeutics AKBA, has filed 0 purchases and 4 sales on the open market. The latest trade was on 23/05/16.

David A. Spellman

SVP, CFO and Treasurer
First filing
23/02/02
Trades
6 trades
Buys / sales
0 / 4
12-month net buying
No record
Last trade
23/05/16

Trading activity

Transactions

Trade type
Open-market sale23/05/1623/05/1863,567 sh$1.07$68,016.69−12.5%
AKBA
Open-market sale23/03/0123/03/037,210 sh2 trades$0.88avg.$6,344.8−1.4%
Open-market sale23/02/2723/03/017,539 sh$0.81$6,106.59−1.4%